Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by Revtenon Dec 09, 2021 11:43pm
153 Views
Post# 34217225

RE:RE:Email Jeffrey Shuren at the FDA here in the US....

RE:RE:Email Jeffrey Shuren at the FDA here in the US....A Lot Better MM!...IMO

Will continue to add this month.....January we will head MUCH HIGHER! Enrolment is going well and with an open trial that is producing results " BETTER Than Our Expectations" the word will get out....buyers will show up.

This volume is STILL not significant! We are talking only $55-60,000 Canadian dollars on the TSX today! And we managed to shave 10% of our market cap!
Not realistic with the amount of proven medicine people. 

Don't be fooled by this......we will go back up sooner than later when the FEW Tax Loss Sellers need to Buy back.

 Night All

STILL Rev-ed UP!
<< Previous
Bullboard Posts
Next >>